Form 8-K - Current report:
SEC Accession No. 0001213900-24-071386
Filing Date
2024-08-21
Accepted
2024-08-21 14:04:20
Documents
16
Period of Report
2024-08-21
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0212056-8k_inmed.htm   iXBRL 8-K 40599
2 NEWS RELEASE, DATED AUGUST 21, 2024 ea021205601ex99-1_inmed.htm EX-99.1 16571
3 GRAPHIC ex99-1_001.jpg GRAPHIC 5102
  Complete submission text file 0001213900-24-071386.txt   284819

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE inm-20240821.xsd EX-101.SCH 3265
5 XBRL DEFINITION FILE inm-20240821_def.xml EX-101.DEF 26195
6 XBRL LABEL FILE inm-20240821_lab.xml EX-101.LAB 35952
7 XBRL PRESENTATION FILE inm-20240821_pre.xml EX-101.PRE 24853
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0212056-8k_inmed_htm.xml XML 4385
Mailing Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8
Business Address 1445-885 WEST GEORGIA ST. VANCOUVER A1 V6C 3E8 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

EIN.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-39685 | Film No.: 241228393
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)